June 15, 2018
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Zelle LLP
- Motley Rice
- Hilliard & Shadowen
- Smith Segura Raphael & Leger
- Durrette Arkema
- Girard Sharp
- Grabar Law
- Garwin Gerstein
- Kaufman & Canoles
- Ventker Henderson
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Fisher & Phillips
- Miller Shah LLP
- Wolcott Rivers
- Faruqi & Faruqi
- Cohen Milstein
- Glasser & Glasser
- Lockridge Grindal
- Goldman Ismail
- Boies Schiller
- Willcox & Savage
- Hagens Berman
- McDermott Will & Emery
- Marcus & Shapira
- Hangley Aronchick
- BoiesBattin
- McGuireWoods
- The Office of Craig C. Reilly
- Nussbaum Law Group
- Crenshaw Ware
- Crowell & Moring
- Kessler Topaz
- Wexler Boley
- Sperling Kenny
- Katten Muchin
- Williams & Connolly
- Gustafson Gluek
- Joseph Saveri Law Firm
- Hartley LLP
- Furniss Davis
- O'Hagan Meyer
- Gibson Dunn
- Radice Law Firm
- Morgan Lewis
- Taus Cebulash
- Berger Montague
- Kirkland & Ellis
- DLA Piper
- Winston & Strawn
- Wilson Sonsini
- Woods Rogers
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- Wegmans Food Markets Inc.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Merck & Co. Inc.
- Fraternal Order of Police
- The Kroger Co.
- Health Net Inc.
- H.D. Smith LLC
- H‑E‑B LP
- Rite Aid Corp.
- Mutual Drug
- Humana Inc.
- Albertsons Cos. Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- CVS Health Corp.
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Zydus Pharmaceuticals Inc.
- Cencora Inc.
- Centene Corp.
- Giant Eagle Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 27, 2023
Merck Says It Paid $573M To Settle Zetia Antitrust Case
Pharmaceutical giant Merck & Co. Inc. paid $573 million to settle antitrust claims this month over allegations it conspired with Glenmark Pharmaceuticals to delay the launch of generic versions of the blockbuster cholesterol drug Zetia, according to first-quarter financial results released Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login